- Report
- November 2023
- 242 Pages
China
From €3951EUR$4,000USD£3,287GBP
- Report
- July 2023
- 132 Pages
Global
From €938EUR$950USD£781GBP
- Report
- March 2023
- 132 Pages
Global
From €938EUR$950USD£781GBP
- Report
- March 2023
- 132 Pages
Global
From €938EUR$950USD£781GBP
- Report
- July 2022
- 132 Pages
Global
From €840EUR$850USD£698GBP
- Report
- July 2022
- 132 Pages
Global
From €840EUR$850USD£698GBP
- Report
- February 2022
United States
From €3457EUR$3,500USD£2,876GBP
- Report
- February 2022
United Kingdom
From €3457EUR$3,500USD£2,876GBP
- Report
- February 2022
Spain
From €3457EUR$3,500USD£2,876GBP
- Report
- February 2022
Japan
From €3457EUR$3,500USD£2,876GBP
- Report
- February 2022
Italy
From €3457EUR$3,500USD£2,876GBP
- Report
- February 2022
Germany
From €3457EUR$3,500USD£2,876GBP
- Report
- February 2022
France
From €3457EUR$3,500USD£2,876GBP
- Report
- July 2024
- 280 Pages
Global
From €2622EUR$2,655USD£2,182GBP
- Report
- April 2023
- 438 Pages
Global
From €3526EUR$3,570USD£2,934GBP
- Report
- March 2023
- 322 Pages
Global
From €3526EUR$3,570USD£2,934GBP
- Report
- February 2023
- 380 Pages
Global
From €3526EUR$3,570USD£2,934GBP
- Report
- December 2022
- 210 Pages
Global
From €3644EUR$3,690USD£3,032GBP
The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics.
The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more